Nymox Pharmaceutical (NYMXF, $0.28) was a top loser over the last three months, falling -3 to $0.28 per share. A.I.dvisor analyzed 913 stocks in the Biotechnology Industry for the 3-month period ending May 2, 2024, and found that of them (4) exhibited an Uptrend while of them (5) demonstrated a Downtrend. A.I.dvisor found 409 similar cases when NYMXF's price dropped within three months. In out of those 409 cases, NYMXF's price went up during the following month. Based on these historical data, A.I. thinks the odds of a Downtrend reversal for NYMXF are